Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ASE Technology Holding Co., Ltd. American Depositary Shares (each representing (NY: ASX )

9.720 +0.250 (+2.64%)
Official Closing Price Updated: 7:00 PM EDT, Mar 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,821,670
Open 9.750
Bid (Size) 9.500 (1)
Ask (Size) 9.850 (1)
Prev. Close 9.470
Today's Range 9.635 - 9.810
52wk Range 8.100 - 12.86
Shares Outstanding 4,408,018,732
Dividend Yield 3.31%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Baker Hughes and Woodside Energy Announce Collaboration Framework to Develop Small-Scale Decarbonization Solution Utilizing Net Power Platform
From Baker Hughes
Via GlobeNewswire
Esperion Partners with CSL Seqirus to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Australia
– Esperion to Receive an Upfront Payment and Near-Term Milestones Along with a Profitable Transfer Price on Product Sales – 
From Esperion Therapeutics, Inc.
Via GlobeNewswire

Performance

YTD
-2.99%
-2.99%
1 Month
-5.45%
-5.45%
3 Month
-2.90%
-2.90%
6 Month
+1.67%
+1.67%
1 Year
-14.44%
-14.44%

More News

Read More
Life360 Reports Record Q4 and FY 2024 Results
From Life360, Inc.
Via GlobeNewswire
Earnings Scheduled For February 13, 2025
Via Benzinga
Current Report ASE Technology
Via Talk Markets
Topics Stocks / Equities
Life360 Enhances Advertising Capabilities with Strategic Acquisition of Fantix’s AdTech AI Platform
From Life360, Inc.
Via GlobeNewswire
ASE Technology Expands In Malaysia: New High-Tech Chip Facility Boosts Semiconductor Growth
Via Benzinga
ASE Expands its Chip Packaging and Testing Facility to Enable Next-Gen Applications
From Advanced Semiconductor Engineering, Inc.
Via Business Wire
Alterity Therapeutics Raises A$40.0 million in Placement
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
Life360 to Announce Q4 and Full Year 2024 Financial Results on February 27, 2025
From Life360, Inc.
Via GlobeNewswire
Dotz Nano to Present at the Small Cap Growth Virtual Investor Conference February 6th
From Virtual Investor Conferences
Via GlobeNewswire
Alterity Therapeutics Announces Positive ATH434 Phase 2 Trial Results in Multiple System Atrophy Led By Robust Clinical Efficacy
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Trump Says Its Time For US To 'Return' To A System That Made It Rich And Powerful As The President Proposes Tariffs On Taiwan: 'Bring Production Back To Our Country'
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
Appendix 4C – Q2 FY25 Quarterly Cash Flow Report
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Baker Hughes Secures Liquefaction Equipment Order for Woodside Louisiana LNG
From Baker Hughes
Via GlobeNewswire
ASE’s Sustainability Efforts Receive International Recognition With a Ranking on the Dow Jones Sustainability Indices for the Ninth Year in a Row
From ASE Technology Holding Co., Ltd.
Via Business Wire
Precious Metals & Critical Materials Virtual Investor Conference: Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
Precious Metals & Critical Materials Virtual Investor Conference Agenda Announced for December 10th and 11th
From Virtual Investor Conferences
Via GlobeNewswire
American Rare Earths to Present at the Precious Metals & Critical Materials Virtual Investor Conference December 11th
From Virtual Investor Conferences
Via GlobeNewswire
Alterity Therapeutics Completes Last Patient Visit in ATH434-201 Phase 2 Clinical Trial in Early-Stage Multiple System Atrophy
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Small Cap Growth Virtual Investor Conference Agenda Announced for December 5th
From Virtual Investor Conferences
Via GlobeNewswire
Life360 Named One of the Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500™
From Life360, Inc.
Via GlobeNewswire
Alterity Therapeutics Appoints Abby Macnish Niven as Company Secretary
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.